Abstract
Monotherapy Activity with the First CD20-Targeted Immunotoxin, MT-3724, in Subjects with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have